サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：輸液薬局管理市場：製品タイプ別、用途別、疾患別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1351429

輸液薬局管理市場：製品タイプ別、用途別、疾患別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Infusion Pharmacy Management Market, By Product Type, By Application, By Diseases, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日
ページ情報
英文 288 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
輸液薬局管理市場：製品タイプ別、用途別、疾患別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年09月01日
発行: AnalystView Market Insights
ページ情報: 英文 288 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

輸液薬局管理市場規模は2022年に417億260万米ドルとなり、2023年から2030年にかけてCAGR 7.4％で拡大

輸液薬局管理市場- 市場力学：

  • 在宅医療サービスの動向が市場成長を牽引
  • 病院を拠点とするクリニックは、輸液のための最も費用のかかる選択肢です。これらの欠点は、費用と患者の不快感に関連しているためです。また、特定の時間帯にしか営業していないクリニックでは、患者は予約のために長時間待たなければならないです。一方、独立型の輸液クリニックは、病院を拠点とするクリニックに比べ、地域に密着しており、価格も安価であるため、より現実的です。このような代替施設が患者の主治医である腫瘍科チームに属さない場合、異なるケアチーム間のコミュニケーション不足により、治療が断片化する可能性があります。これに伴い、価格設定は独立型の輸液クリニックに匹敵するように見えるが、在宅輸液は病院ベースのクリニックよりもかなり安価です。この方法は、患者が自宅で輸液を受けられるという点で、移動が必要な独立型の輸液クリニックより優れています。その結果、上記の要因が世界の輸液薬局管理市場の成長を後押しすると予測されています。しかし、熟練した専門家の不足と高コストが市場成長の妨げになると予想されます。

輸液薬局管理市場-セグメンテーション分析：

  • 世界の輸液薬局管理市場は、製品タイプ、用途、疾患、地域に基づいて区分されます。
  • 製品タイプにより、抗菌薬、疼痛管理、体内栄養、抗生物質、その他の4つに分類されます。疼痛管理分野は急速な成長を目の当たりにしています。これは、帯状疱疹後神経痛、糖尿病性神経障害、線維筋痛症、幻肢痛、糖尿病性神経障害、神経障害性疼痛、脳卒中や脊髄に関連する中枢性疼痛など、複数の疼痛症候群を治療するためです。さらに、抗生物質分野が最も高い収益シェアを占めると予測されています。抗生物質は、動物や人間の細菌感染症の治療に使われる薬です。抗生物質は、細菌を除去したり、細菌の発育や繁殖を困難にしたりすることでこれを実現します。
  • 市場は用途によって外来手術センター、在宅医療、病院・診療所の3つに分類されます。病院・診療所セグメントは、予測期間中も優位性を維持しそうです。同分野の需要は、様々な疾患を抱える患者の増加に起因しています。在宅ケア分野は、在宅輸液療法の利点により、最も高い成長率が見込まれています。このサービスは、患者が最も快適と感じる環境で治療を受ける機会を提供します。

輸液薬局管理市場-地理的洞察

輸液薬局管理市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国ごとにさらに分割されます。予測期間中、北米が市場を独占すると見られています。同地域の拡大は、老人人口の増加と慢性疾患患者の増加に起因しています。さらに、アジア太平洋市場は、インドや中国などの新興国における最先端ヘルスケア施設の利用拡大により、大幅に上昇する可能性が高いです。加えて、輸液治療の利点に対する社会的認知度の高まりと、大規模な患者人口の存在が、市場の収益成長を促進すると予想されます。

輸液薬局管理市場-競合情勢：

輸液治療は経口薬よりも効率的であるため、市場成長を後押しします。さらに、大手ヘルスケアテクノロジー企業が中小企業を買収するにつれ、市場はソリューションのポートフォリオを拡大するために統合が進んでいます。この統合の結果、エンド・ツー・エンドの輸液薬局管理機能を提供する包括的なプラットフォームが開発されています。さらに、市場参入企業は研究開発活動、提携、協業などさまざまな戦略を打ち出しています。例えば、世界ヘルスケア企業のAmerisourceBergenは2022年4月、病院や医療システムの在宅輸液サービスラインの立ち上げや最適化を支援するプログラムを発表しました。さらに、サイト・オブ・ケア戦略の重要性が高まるにつれ、外来輸液センターの業績が好調な医療システムは、潜在的なケアギャップを防ぐために在宅輸液をますます活用するようになっています。

目次

第1章 輸液薬局管理市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 輸液薬局管理の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 輸液薬局管理業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 輸液薬局管理市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 輸液薬局管理市場情勢

  • 輸液薬局管理市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 輸液薬局管理市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 抗菌性
    • 疼痛管理
    • 体内の栄養補給
    • 抗生物質
    • その他

第8章 輸液薬局管理市場- アプリケーション別

  • 概要
    • アプリケーション別のセグメントシェア分析
    • 外来手術センター
    • ホームケア
    • 病院とクリニック

第9章 輸液薬局管理市場- 疾患別

  • 概要
    • 疾患別セグメントシェア分析
    • がん
    • 痛みに関連する病気
    • 糖尿病
    • その他

第10章 輸液薬局管理市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 輸液薬局管理業界

  • 競合ダッシュボード
  • 企業プロファイル
    • PharMerica Corporation
    • Sentara Healthcare
    • Magellan Rx Management LLC
    • CARECENTA INC.
    • Brightree
    • SSRx
    • CVS Health
    • MCKESSON CORPORATION
    • ContinuumRx
    • Prochant LLC
    • CarepathRx
    • Providence
    • Inovalon
    • Cigna
    • Centene Corporation
    • OSF Healthcare System
    • Norton Healthcare

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Infusion Pharmacy Management Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Infusion Pharmacy Management Market, by Product Type2018-2030 (USD Million)
  • TABLE Infusion Pharmacy Management Market: ApplicationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Infusion Pharmacy Management Market, by Application2018-2030 (USD Million)
  • TABLE Infusion Pharmacy Management Market: Diseases Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Diseases
  • TABLE Global Infusion Pharmacy Management Market, by Diseases 2018-2030 (USD Million)
  • TABLE Infusion Pharmacy Management Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Infusion Pharmacy Management Market, by Region 2018-2030 (USD Million)
  • TABLE North America Infusion Pharmacy Management Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Infusion Pharmacy Management Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Infusion Pharmacy Management Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Infusion Pharmacy Management Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Europe Infusion Pharmacy Management Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Infusion Pharmacy Management Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Infusion Pharmacy Management Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Infusion Pharmacy Management Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Asia Pacific Infusion Pharmacy Management Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Infusion Pharmacy Management Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Infusion Pharmacy Management Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Infusion Pharmacy Management Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Latin America Infusion Pharmacy Management Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Infusion Pharmacy Management Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Infusion Pharmacy Management Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Infusion Pharmacy Management Market, by Diseases, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Infusion Pharmacy Management Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Infusion Pharmacy Management Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Infusion Pharmacy Management Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Infusion Pharmacy Management Market, by Diseases, 2018-2030 (USD Million)
目次
Product Code: ANV1676

REPORT HIGHLIGHT

Infusion pharmacy management market size was valued at USD 41,702.6 Million in 2022, expanding at a CAGR of 7.4% from 2023 to 2030.

Medications or drugs are administered during infusion treatment by a sterilized catheter or needle. A professional healthcare provider secures them and regularly inserts them in the patient's vein. Additionally, only patients whose health has not yet improved and who do not react to oral treatment are often recommended this therapy Moreover, at the infusion pharmacy antiviral, antibiotics, antifungals, pain management medications, and nutritional pharmaceuticals are infused into the patient's body via a catheter or needle. The infusion medicine system is utilized to treat several diseases, such as diabetes, cancer, gastrointestinal disorders, and illnesses related to pain.

Infusion Pharmacy Management Market - Market Dynamics:

  • The rise in the trend of homecare services drives the market growth
  • Hospital-based clinics are the most costly option for infusion, as these drawbacks are related to expense and patient discomfort. In addition, patients would have to wait longer for appointments if a clinic only operates within certain hours. On the other side, freestanding infusion clinics may be more practical as compared to hospital-based clinics, as their given place around the community and less expensive prices. If these alternate places do not belong to the patient's primary oncology team, treatment may be fragmented because of poor communication between the different care teams. In line with this, even though the pricing seems comparable to that of freestanding infusion clinics, home infusion s considerably less costly than hospital-based clinics. This method is superior for standalone infusion clinics that need transportation simply because it helps patients to receive infusions at home. As a result, above mention factors are projected to boost the growth of the global infusion pharmacy management market. However, the lack of skilled professionals and high costs are expected to hinder market growth.

Infusion Pharmacy Management Market - Key Insights:

  • As per the analysis shared by our research analyst, the global infusion pharmacy management market is estimated to grow annually at a CAGR of around 7.4% over the forecast period (2023-2030)
  • The infusion pharmacy management industry is projected to grow at a significant rate due to the growing awareness home care services
  • Based on product type segmentation, pain management was predicted to show maximum market share in the year 2022
  • The rising prevalence of chronic diseases including diabetes, pain-related diseases, gastrointestinal disorders, and cancer is the primary factor fueling the market growth
  • Pharmaceutical companies taken numerous initiatives to develop the healthcare infrastructure and make technological advancements that will drive the market growth

Infusion Pharmacy Management Market- Segmentation Analysis:

  • The global infusion pharmacy management market is segmented on the basis of product type, application, diseases, and region.
  • The market is divided into four categories based on product type: antimicrobial, pain management, internal nutrition, antibiotics, and others. The pain management segment is accounted witnessed speedy growth. This is attributed to treating several pain syndromes, including post-herpetic neuralgia, diabetic neuropathy, fibromyalgia, phantom limb pain, diabetic neuropathy, neuropathic pain, and central pain related to stroke or spinal cord. Moreover, the antibiotics segment is projected to hold the highest revenue share. Antibiotics are medicine used for treating bacterial infections in both animals and humans. They achieve this by removing the bacteria or making it tougher for them to develop and reproduce.
  • The market is divided into three categories based on application: ambulatory surgical centers, homecare, and hospital & clinic. The hospital & clinic segment is likely to maintain its dominance during the forecast period. The segment demand is attributable to the increasing cases of patients with various diseases. The homecare segment is expected to experience the highest growth rate, due to the benefits of home infusion therapy. This service offers patients the opportunity to receive therapy in the setting in which they feel most comfortable.

Infusion Pharmacy Management Market- Geographical Insights

Geographically, the infusion pharmacy management market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is accounted to dominate the market during the forecast period. The expansion in the region is attributed to the rising geriatric population and the increasing cases of chronic disease. Moreover, the Asia-Pacific market is likely to rise significantly due to the expanding usage of cutting-edge healthcare facilities in emerging nations such as India and China. In addition, it is expected that the growing public awareness of the benefits of infusion treatment and the presence of a sizeable patient population will fuel the market revenue growth.

Infusion Pharmacy Management Market- Competitive Landscape:

Infusion medication is more appropriate than oral medication, since it is more efficient, propelling the market growth. Moreover, as larger healthcare technology companies acquire smaller players the market is witnessing consolidation to expand their portfolio of solutions. As a result, of this integration, comprehensive platforms that offer end-to-end infusion pharmacy management capabilities have been developed. Furthermore, market players are including various strategies such as R&D activities, partnerships, and collaboration. For instance, in April 2022, AmerisourceBergen a global healthcare company announced a program to assist hospitals and health systems launch or optimizing home infusion service lines. Moreover, as site-of-care strategies grow in importance, health systems with strong outpatient infusion center performance are increasingly leveraging home infusion to prevent potential care gaps, especially as therapeutic advancements continue to increase the range of home treatments available.

Recent Developments:

For instance, in September 2021, B. Braun Medical Inc launched its new CARESAFE™ IV Administration Sets with an Optional AirStop component. Additionally, they offer an added level of protection for the environment and, most essentially, to patients from the potential health risks associated with exposure to these chemicals.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFUSION PHARMACY MANAGEMENT MARKET KEY PLAYERS

  • PharMerica Corporation
  • Sentara Healthcare
  • Magellan Rx Management LLC
  • CARECENTA INC.
  • Brightree
  • SSRx
  • CVS Health
  • MCKESSON CORPORATION
  • ContinuumRx
  • Prochant LLC
  • CarepathRx
  • Providence
  • Inovalon
  • Cigna
  • Centene Corporation
  • OSF Healthcare System
  • Norton Healthcare

GLOBAL INFUSION PHARMACY MANAGEMENT MARKET, BY PRODUCT TYPE

  • Antimicrobial
  • Pain Management
  • Internal Nutrition
  • Antibiotics
  • Others

GLOBAL INFUSION PHARMACY MANAGEMENT MARKET, BY APPLICATION

  • Ambulatory Surgical Centers
  • Homecare
  • Hospital & Clinic

GLOBAL INFUSION PHARMACY MANAGEMENT MARKET, BY DISEASES

  • Cancer
  • Pain Related Diseases
  • Diabetes
  • Others

GLOBAL INFUSION PHARMACY MANAGEMENT MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Infusion Pharmacy Management Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Infusion Pharmacy Management Market Snippet by Product Type
    • 2.1.2. Infusion Pharmacy Management Market Snippet by Application
    • 2.1.3. Infusion Pharmacy Management Market Snippet by Diseases
    • 2.1.4. Infusion Pharmacy Management Market Snippet by Country
    • 2.1.5. Infusion Pharmacy Management Market Snippet by Region
  • 2.2. Competitive Insights

3. Infusion Pharmacy Management Key Market Trends

  • 3.1. Infusion Pharmacy Management Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Infusion Pharmacy Management Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Infusion Pharmacy Management Market Opportunities
  • 3.4. Infusion Pharmacy Management Market Future Trends

4. Infusion Pharmacy Management Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Infusion Pharmacy Management Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Infusion Pharmacy Management Market Landscape

  • 6.1. Infusion Pharmacy Management Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Infusion Pharmacy Management Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022&2030 (%)
    • 7.1.2. Antimicrobial
    • 7.1.3. Pain Management
    • 7.1.4. Internal Nutrition
    • 7.1.5. Antibiotics
    • 7.1.6. Others

8. Infusion Pharmacy Management Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 8.1.2. Ambulatory Surgical Centers
    • 8.1.3. Homecare
    • 8.1.4. Hospital & Clinic

9. Infusion Pharmacy Management Market - By Diseases

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Diseases, 2022&2030 (%)
    • 9.1.2. Cancer
    • 9.1.3. Pain Related Diseases
    • 9.1.4. Diabetes
    • 9.1.5. Others

10. Infusion Pharmacy Management Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Infusion Pharmacy Management Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Infusion Pharmacy Management Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Infusion Pharmacy Management Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Infusion Pharmacy Management Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Infusion Pharmacy Management Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Infusion Pharmacy Management Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. PharMerica Corporation
    • 11.2.2. Sentara Healthcare
    • 11.2.3. Magellan Rx Management LLC
    • 11.2.4. CARECENTA INC.
    • 11.2.5. Brightree
    • 11.2.6. SSRx
    • 11.2.7. CVS Health
    • 11.2.8. MCKESSON CORPORATION
    • 11.2.9. ContinuumRx
    • 11.2.10. Prochant LLC
    • 11.2.11. CarepathRx
    • 11.2.12. Providence
    • 11.2.13. Inovalon
    • 11.2.14. Cigna
    • 11.2.15. Centene Corporation
    • 11.2.16. OSF Healthcare System
    • 11.2.17. Norton Healthcare

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us